Dr. Mazen K. Khalil, MD

Dr. Khalil practices at Savannah Multispecialty Associates in Savannah, Georgia.

Dr. Khalil's NPI, 1679725808, was assigned on October 21, 2008. Dr. Khalil holds Tennessee license 65874.

Dr. Khalil's primary practice is Savannah Multispecialty Associates, at 4750 Waters Ave, Savannah, GA 31404 in Chatham County. The practice phone is (615) 372-5426.

Dr. Khalil's primary practice is Savannah Multispecialty Associates in Savannah, Georgia. Dr. Khalil is also affiliated with Memorial Health University Medical Center. The medical group on file is Memorial Health University Physicians, Heart Care - Waters Ave. Dmand AI also links Dr. Khalil to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khalil practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Khalil's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Khalil's licenses on file in 2 states: Tennessee and South Carolina.

CMS data shows 1,152 Medicare services from Dr. Khalil across 20 procedure codes in 2024, for 465 Medicare patients. Medicare paid $91,966 for them.

CMS counts 465 Medicare patients who saw Dr. Khalil in 2024. The largest group is 65 to 74, with 192 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khalil's median patient age at 71, with 55% women.

In 2024, Dr. Khalil wrote 2,728 Medicare Part D claims for 522 patients. 86% of them were for generic drugs. CMS names the drug for 2,566 of them, across 39 drugs with 11 or more claims each, at $417,985 in total drug cost. In 2023, CMS named 2,706 claims across 35 drugs.

Dr. Khalil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of coronary angioplasty and stenting by Dr. Khalil, more than 52% of the clinicians it reports for that procedure.

CMS Open Payments shows 221 general payments to Dr. Khalil from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Abbott Laboratories paid the most, $1,923.